IQVIA艾昆纬：2025年解锁生物仿制药报告-从复杂患者途径的骨质疏松症案例研究中学习（英文版）

Biosimilar use is growing globally with more physicians becoming experienced and comfortable with their use. These biosimilars have also provided substantial savings for the overall healthcare system.In 2023, IQVIA Institute published a report highlighting the importance of physician perspectives on biosimilars for their optimal utilization. This viewpoint continues to remain important and relevant, particularly as biosimilars enter new disease areas, including ones which involve complex inte